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p-Nitrobenzoic acid (p-NBA) is widely
used in explosive and dyestuff industries
and as a chemical intermediate. pNBA was
tested using the RACB protocol to follow
up on preliminary data from a 13-week
prechronic study that found testicular atro-
phy and estrous cycle irregularities in
B6C3F1 mice, and as a structure-activity
study in conjunction with other nitroben-
zoic acids. Data from a 2-week dose-range-
finding study (Task 1) were used to set
exposure concentrations for theTask2 con-
tinuous cohabitation study at 0.35, 0.75,
and 1.50% in feed. Based on mean feed
consumption and body weight, the esti-
mated daily dosages were approximately
0.5, 1.1, and 2.4 g/kg/day.
In theFogeneration, two females died in
the control group: one during delivery, and
the other ofunidentified causes (autolysis
precluded identification ofcause ofdeath).
Postpartum dam weights in the top dose
group were 10 to 15% lower than controls
for all litters; in the middle dose group,
postpartum body weight was reduced by 7
to 9% forthe first threelitters.
Fertility in the low dose group was the
same as controls, but at the middle dose
level, fewer pairs delivered a fourth and fifth
litter. Fewer pairs delivered all litters at the
high dose; there were fertility reductions
recorded for all litters. This is indicated also
by the observation that, while the control
group delivered a mean of4.9 litters per
pair, the middle andhigh dose groups deliv-
ered 4.5 and 3.6 litters, respectively. These
litters were also smaller by22 and 38%. Pup
weight adjusted for litter size was reduced at
all dose levels by 6, 17, and 18%, respec-
tively, from low to high dose. Finally,
cumulative days to deliver each litter was
increased at the top dose for all litters after
the first, and for the middle dose group's
third and fourth litters.
The last litter was reared by the dam
until weaning. While survival to weaning
was not affected by p-NBA, pup body
weights were reduced at all dose levels.
Although females were affected more than
male pups at the low dose, the weight of
both sexes was reduced in the middle and
high dose groups by 10 to 30%.
Because ofthe significant reproductive
effects observed during Task 2, a crossover
mating trial was performed using the con-
trol and middle dose mice. Given previous
data collected at high doses indicating that
both sexes were affected, it was thought
that using a lower effective dose might help
identify the most susceptible gender. In
this crossover, pairs containing treated
females delivered approximately 40% fewer
live pups, and their weight was approxi-
mately 25% lower than the controls. Pairs
with treated males were indistinguishable
from controls.
After the litters were delivered in the
crossover, the control and middle dose Fo
adults were killed and necropsied. Females
treated with 0.75% p-NBA weighed 9%
less than controls, and adjusted kidney
weight was 9% less than controls. Estrous
cycle length was also greater than controls:
5.36 versus 4.92 days. Histologically, there
was a treatment-related increase in hepati-
tis, although the treated animals had fewer
kidney and ovary findings than the con-
trols. There were no differences between
the control and middle-dose males in body
or organ weights, or in any sperm parame-
ter. Histologically, treated males also had
fewer renal findings, no increase in hepatic
abnormalities, and a greater incidence of
spermatogenic disturbances.
The reproductive performance of the
second generation was tested using all
dose groups. Litter size was reduced by 23
to 24% at the middle and high dose
levels, while adjusted pup weight was
reduced in all exposed groups (13 to 27%,
respectively). Thus, p-NBA had similar
effects on second-generation fertility as in
the first generation.
After the F2 pups were delivered and
evaluated, the Fl adults were killed and
necropsied. Female body weight was
reduced by 7, 10, and 13% (low to high
dose, respectively), while right ovary weight
was reduced by 22, 23, and 32%. Adjusted
liver weight was increased by 8 and 11% in
the middle and high dose groups. Estrous
cycle length was unaltered by p-NBA con-
sumption. Histologically, there was a slight
increase in hepatitis in treated mice and
more cystic ovaries in treated females. Male
bodyweightwas reduced by9, 14, and 17%
(low to high dose levels, respectively).
Relative kidneyweightwas reduced by 13%
at all dose levels, relative seminal vesicle
weightwas reduced by 11 to 15% atall dose
levels, absolute testis weight was reduced by
18 and 23% in the middle and high dose
groups, and relative epididymis weight was
reduced by6, 11, and 17% in the low, mid-
dle and high dose groups. Interestingly,
sperm measures were unaffected by p-NBA
consumption. There were no histologic dif-
ferences betweenthegroups.
In summary, consumption ofp-nitro-
benzoic acid reduced reproductive perfor-
mance (numbers oflitters, numbers ofpups,
pup body weight) at levels that did not (Fo
low and middle dose) or did (Fo high dose
and F1) have adverse effects on adult body
weight. Females appeared more sensitive to
the toxicity than males. These effects
occurred in the presence(FO) or absence (F1)
ofchanges in estrous cyclelength.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB90253766
Chemical: p-Nitrobenzoic Acid
CAS#: 62-23-7
Mode of exposure: Feed
Species/strain: Swiss CD-1 mice
F generation Dose concentration - 0.35% 0.75% 1- 0-
Body weight
Kidney weighta
Liverweight' .
Mortality
Feed consumption -. .. -,- _, _
Waterconsumption . .
Clinical_signs _ , _ _ , _ ,_
x litters/pair -------- ------ --- ,_
#livepups/litter; pupwt./litter -, __,J_
Cumulative days to litter _ __ _ _
Absolutetestis,epididymisweight' _ _ .. .. * - -
Sexaccessoryglandweight8(prostate, seminal vesicle) -
Epidid. spermparameters (#,motility,morphology) * _, _
Estrous_cycle_length
[Determinationofaffectedsex(crossover) J Male Female Both
Dose level I - - - I0.75%-
F, goneraton Dose concentration 0.35% 0.75% 1 0
Pup growth to weaning
Mortality -,__ ,
Adultbodyweight 4, 4, 4,4
Kidneyweight' i 4e 4 -
Liverweight' ,t_
Feedconsumption _ t t tt t
Waterconsumption . .
Clinical signs
Fertilityindex
live pups/litter; pupwt./litter - 4-- - - - __- - - - - --_____-__-_-_-_-_-___
Absolute testis,_epididymis weight8a_
Sexaccessoryglandweight'(prostate,seminalvesicle) - , 4 I _
Epidid. sperm parameters It,motility,morphology) - -. , - _- _-
Estrous cycle length - ---
Affected sex? Female
Studyconfounders: None
NOAELreproductivetoxicity: <0.35%
NOAELgeneraltoxicity: Fo,0.75%;F1,<0.35%
F1 more sensitivethanFo? Yes
Postnataltoxicity: Yes
Legend:-, no change; *, no observation; T or.1, statistically significant change (p<0.05); , no change in males orfemales. "Adjusted for bodyweight.
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